483 results found

六、新薬が上市の承認を得た場合、2021年6月1日から、特許権者は改正後の特許法第42条第3項により特許権保護期間の補償を請求することができ

A series of drafts for comments of laws and regulations have been released by relevant government authorities recently and we prepared a series of "brief" on these topics.

As reported in my previous article (see below), the Chinese Patent Examination Guidelines 2023 was announced by the CNIPA on 21 December 2023 ...

China's rapid economic development, rising middle class, and evolving consumer preferences have created a fertile environment for international food franchises, particularly those originating from the United States, to expand and flourish.

自国务院于2015年发布《关于改革药品医疗器械审评审批制度的意见》（国发〔2015〕44号）并启动药品医疗器械审评审批制度改革工作以来，我国不断߾

최근 아주 인기가 많는 특허, 특허번호...

In recent years, an increasing number of multinational pharmaceutical and medical device companies have been exploring local manufacturing options in China.

In recent years, China has emerged as a significant global player in the pharmaceutical sector, not only due to its vast market potential but also because of its evolving intellectual property (IP) framework.

In recent years, the amount of patent infringement litigations among pharmaceutical companies have been increasing year by year

China's role in the global pharmaceutical innovation market is undergoing a substantial shift.

近期，医药行业正掀起一股"管线分拆项目"（"Spin off-NewCo"，或称"SON"模式）的热潮。短短两个月，笔者即接手了近十起管线分拆项目。

随着新型冠状病毒肺炎疫情（以下简称"肺炎疫情"）...

On June 29, 2022, the National Medical Products Administration ("NMPA") publicly released the "Implementation Plan for Supporting Hong Kong and Macao Drug Marketing Authorization Holders...

The National Medical Products Administration (NMPA) issued the Implementation Measures for Drug Regulatory Data Protection and the Drug Regulatory Data Protection Working Procedures on March 19, 2025.

中国《专利法》第四次修改即将于2021年6月1日生效，与之相关的《专利法实施细则》...

《商标法》十条一款七项规定了带有欺骗性...

In the first article of this series, we elaborated on the regulatory framework of the Pharmaceuticals patent linkage system of China, along with the current status of case acceptance, applicable conditions...